26133759|t|Protective Effects of Dihydrocaffeic Acid, a Coffee Component Metabolite, on a Focal Cerebral Ischemia Rat Model.
26133759|a|We recently reported the protective effects of chlorogenic acid (CGA) in a transient middle cerebral artery occlusion (tMCAo) rat model. The current study further investigated the protective effects of the metabolites of CGA and dihydrocaffeic acid (DHCA) was selected for further study after screening using the same tMCAo rat model. In the current study, tMCAo rats (2 h of MCAo followed by 22 h of reperfusion) were injected with various doses of DHCA at 0 and 2 h after onset of ischemia. We assessed brain damage, functional deficits, brain edema, and blood-brain barrier damage at 24 h after ischemia. For investigating the mechanism, in vitro zymography and western blotting analysis were performed to determine the expression and activation of matrix metalloproteinase (MMP)-2 and -9. DHCA (3, 10, and 30 mg/kg, i.p.) dose-dependently reduced brain infarct volume, behavioral deficits, brain water content, and Evans Blue (EB) leakage. DHCA inhibited expression and activation of MMP-2 and MMP-9. Therefore, DHCA might be one of the important metabolites of CGA and of natural products, including coffee, with protective effects on ischemia-induced neuronal damage and brain edema. 
26133759	22	41	Dihydrocaffeic Acid	Chemical	MESH:C000995
26133759	85	102	Cerebral Ischemia	Disease	MESH:D002545
26133759	103	106	Rat	Species	10116
26133759	161	177	chlorogenic acid	Chemical	MESH:D002726
26133759	179	182	CGA	Chemical	MESH:D002726
26133759	199	231	middle cerebral artery occlusion	Disease	MESH:D020244
26133759	233	238	tMCAo	Disease	MESH:D020244
26133759	240	243	rat	Species	10116
26133759	335	338	CGA	Chemical	MESH:D002726
26133759	343	362	dihydrocaffeic acid	Chemical	MESH:C000995
26133759	364	368	DHCA	Chemical	MESH:C000995
26133759	432	437	tMCAo	Disease	MESH:D020244
26133759	438	441	rat	Species	10116
26133759	471	476	tMCAo	Disease	MESH:D020244
26133759	477	481	rats	Species	10116
26133759	564	568	DHCA	Chemical	MESH:C000995
26133759	597	605	ischemia	Disease	MESH:D007511
26133759	619	631	brain damage	Disease	MESH:D001925
26133759	633	652	functional deficits	Disease	MESH:D001289
26133759	654	665	brain edema	Disease	MESH:D001929
26133759	677	690	brain barrier	Disease	MESH:C536830
26133759	712	720	ischemia	Disease	MESH:D007511
26133759	866	905	matrix metalloproteinase (MMP)-2 and -9	Gene	81686;81687
26133759	907	911	DHCA	Chemical	MESH:C000995
26133759	965	978	brain infarct	Disease	MESH:D020520
26133759	987	1006	behavioral deficits	Disease	MESH:D019958
26133759	1033	1043	Evans Blue	Chemical	MESH:D005070
26133759	1045	1047	EB	Chemical	MESH:D005070
26133759	1058	1062	DHCA	Chemical	MESH:C000995
26133759	1102	1107	MMP-2	Gene	81686
26133759	1112	1117	MMP-9	Gene	81687
26133759	1130	1134	DHCA	Chemical	MESH:C000995
26133759	1180	1183	CGA	Chemical	MESH:D002726
26133759	1254	1262	ischemia	Disease	MESH:D007511
26133759	1271	1286	neuronal damage	Disease	MESH:D009410
26133759	1291	1302	brain edema	Disease	MESH:D001929
26133759	Negative_Correlation	MESH:D002726	MESH:D020244
26133759	Negative_Correlation	MESH:C000995	MESH:D007511
26133759	Negative_Correlation	MESH:C000995	81687
26133759	Negative_Correlation	MESH:C000995	MESH:D019958
26133759	Negative_Correlation	MESH:C000995	81686
26133759	Negative_Correlation	MESH:C000995	MESH:D001929
26133759	Negative_Correlation	MESH:C000995	MESH:D005070
26133759	Negative_Correlation	MESH:C000995	MESH:D020520
26133759	Negative_Correlation	MESH:C000995	MESH:D009410
26133759	Negative_Correlation	MESH:C000995	MESH:D002545
26133759	Comparison	MESH:C000995	MESH:D002726

